Objective Using updated laboratory standards as the reference, we aimed to compare point-of-care (POC) maternal capillary glucose testing with the diagnostic accuracy of reference and customary venous samples.
Introduction
After publication of the landmark Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study in 2008, the recommendations for the diagnosis of GDM were revised. [1] [2] [3] The glucose cut-off points were lowered and the diagnosis may now be based on one abnormal result, not two as previously. 2 Although international consensus on the new criteria remains elusive, the incidence of GDM has risen sharply in many maternity services. [4] [5] [6] [7] [8] [9] [10] Little attention has been paid, however, to the 2011 publication by the National Association of Clinical Biochemists (NACB) of revised laboratory standards for the diagnosis of GDM, which are stricter than those applied in the HAPO study. 11, 12 To stabilise glucose and prevent in vitro glycolysis from lowering plasma glucose measurements, the latest standards recommend that samples should be collected in a fluoride-containing tube, placed on an ice-slurry as previously recommended, and that plasma should be separated by centrifugation within 30 minutes of phlebotomy, not 60 minutes. 11, 13 If this is not possible, tubes containing a rapidly-acting glycolysis inhibitor such as citrate should be used. 11 Strict implementation of the revised clinical and laboratory standards means that 38% of women screened selectively with a one-step 75-g OGTT may be diagnosed with GDM. 14, 15 Adherence to the NACB laboratory standards is challenging because it may not be possible to use an iceslurry or to perform centrifugation within 30 minutes. National surveys in Europe have shown that the customary pre-analytical handling of glucose samples does not adhere to the NACB recommendations. [16] [17] [18] Failure to implement these pre-analytical standards leads to cases of GDM being missed and the opportunity to treat these cases lost, with potentially serious clinical consequences. 14, 15, [19] [20] [21] We have therefore suggested that the customary practice of using FE tubes without strict implementation of the NACB recommendations (placement on an ice-slurry, centrifugation and analysis within 30 minutes) should be abandoned. 22 One possible solution to the challenge of in vitro glycolysis in OGTT samples is point-of-care (POC) testing. To date, POC glucose testing has been disappointing for diagnostic purposes. This may be because the index test was benchmarked against reference standards that were imprecise in terms of diagnostic accuracy. 23 This study aimed to evaluate the use maternal capillary glucose testing for the diagnosis of GDM in women being screened selectively using a one-step 75-g OGTT. 2 We compared the results with the reference standard, implementing the updated 2011 laboratory recommendations, and with the customary standards implemented in maternity services worldwide.
Methods
The Coombe Women and Infants University Hospital is one of the largest maternity units in Europe; in 2014, 8632 women delivered a baby weighing 500 g or more. 24 The hospital accepts women from all social groups across the urban-rural divide. All women have their body mass index calculated at the first prenatal visit based on the measurement of their weight and height. Clinical and sociodemographic details are computerised and women are screened selectively according to national guidelines with a one-step 75-g OGTT at 26-28 weeks' gestation. 4, 24 Women were recruited with informed consent when they presented to the Perinatal Centre for their OGTT. Women who were <18 years old, who had multiple pregnancies, who were unable to understand English or who were taking medication that would affect glucose metabolism were excluded. All women were instructed to fast from midnight and all glucose loads were administered before 10:00 hours.
At the time of phlebotomy at fasting, 1 hour and 2 hours, three blood samples were taken. The first venous sample was collected into a fluoride-EDTA tube and given to the midwifery staff for transport to the laboratory as usual (customary practice). The second venous sample was put into a fluoride-EDTA tube, placed on an iced slurry and transported immediately to the laboratory for cell separation and measurement in accordance with the latest guidelines from the National Association for Clinical Biochemistry. 11 This was used as the reference standard for the study.
A third capillary whole blood sample was obtained by a member of the research team following the standard procedures for glucometry in the hospital using the Bayer CON-TOUR â XT Meter. The capillary blood samples were collected from a fingertip, after careful washing of the woman's hands using water alone. The glucometer was calibrated every morning before use with the standard test solution provided. Both venous plasma samples were analysed using the hexokinase method (Beckman Coulter AU 640). The laboratory is accredited by the Irish National Accreditation Board.
The primary outcome was the number of women diagnosed with GDM according to the IADPSG criteria. 2 The secondary outcome was the mean glucose level for each test. In 2014, 672 cases of GDM were diagnosed from selective screening of our hospital population using customary practices, giving an incidence of 7.7%. 24 Post hoc analyses were performed by adjusting the POC measurements. We adjusted the fasting cut-off value because it is the measurement that using customary practices is most sensitive to glycolysis over time, and compared sensitivity, specificity, PPV, NPV and accuracy against the reference standard.
Differences in glucose concentrations were determined using a one-way ANOVA analysis with multiple comparisons, using the NACB optimal conditions as the reference test (reference). Linear regression analysis was performed using GraphPad PRISM 6 for Mac, with reference conditions as the X-factor. Bland-Altman Plots were also used to show differences between reference measurements and each method: customary venous plasma and capillary POC. Differences in the diagnosis of GDM as a categorical 'yes' or 'no' were compared using a chi-square test. Significance was reached when P < 0.05. The study was approved by the Hospital Research Ethics Committee.
Results
The mean age of the 108 women studied was 33.0 AE 5.4 years, the mean BMI was 28.2 AE 5.9, the mean gestation at the time of the OGTT was 27.6 AE 2.1 weeks, 38.9% (n = 42) were nulliparas, 28.8% (n = 36) were obese and 46.7% (n = 50) had a family history of diabetes. Table 1 compares the mean glucose results for POC measurements and customary plasma measurements with the reference plasma measurements. Table 2 compares the number of abnormal results for the fasting, 1-hour and 2-hour samples for the point-of-care glucose measurements and the customary plasma measurements with the number of abnormal results from benchmark reference plasma measurements. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for the reference and index tests are shown in Table 3 .
Glucose concentration measured under customary conditions correlated with the reference conditions for the fasting (P < 0.001; best fit 0.91 AE 0.03; 95% CI 0.84-0.98), 1-hour (P < 0.001; best fit 0.99 AE 0.01, 95% CI 0.97-1.1) and 2-hour measurements (P < 0.001; best fit 0.98, 95% CI 0.95-1.02) as shown in Figure 1 .
Glucose concentration measured using capillary POC correlated with reference conditions for the fasting (P < 0.001; best fit 0.80 AE 0.08; 95% CI 0.64-0.97), 1-hour (P < 0.001; best fit 0.85 AE 0.03, 95% CI 0.79-0.91) and 2-hour measurements (P < 0.001; best fit 0.91 AE 0.04, 95% CI 0.82-0.97) as shown in Figure 2 . None of the POC measurements unadjusted for capillary blood correlated as well as customary venous measurements did.
As fasting capillary glucose using POC correlated less strongly with reference measurements, we modelled lower POC cut-off points for the diagnosis of GDM. The use of an adjusted POC (aPOC) cut-off of ≥4.8 mmol/l, a 1-hour cut-off of ≥10.0 mmol/l, and a 2-hour cut-off of ≥8.5 mmol/l correlated best with the reference diagnostic criteria with a sensitivity of 92.5%, specificity of 76.5%, PPV of 69.8%, NPV of 94.5%, and accuracy of 82.4%, as shown in Table 3 ; all of which were higher when compared with customary measurements (all P < 0.01).
Discussion

Main findings
Using the latest IADPSG clinical recommendations and the most recent NACB laboratory recommendations as the reference standards, we found that the accuracy of POC glucose measurements with the fasting level adjusted for capillary-venous differences was superior to that of customary glucose measurements in making the diagnosis of GDM in women screened selectively with a one-step 75-g OGTT. This finding has potential applications for obstetric settings where laboratory standards are not properly implemented or where clinical testing is performed remote from the site of the laboratory. Potentially, the strict implementation of POC glucose testing may minimise misdiagnosis of GDM, may be more convenient for the woman and may be less costly to service providers.
Strengths and limitations
An important strength of this study is that, unlike previous studies, the latest NACB laboratory recommendations for accurate measurement of glucose were strictly implemented POC, point-of-care; aPOC, adjusted POC. Cut-off of ≥4.8 mmol/l, a 1-hour cut-off of ≥10.0 mmol, and a 2-hour cut-off of ≥8.5 mmol/l. *Some overlap. **Chi-square test. as the reference standard for evaluating the POC glucose measurement. Furthermore, previous studies evaluating POC testing have compared its diagnostic accuracy with OGTTs where the pre-analytical handling of venous blood was suboptimal and, thus, the diagnosis of GDM may have been missed. To our knowledge, this is the first study to evaluate the use of POC glucose testing in the diagnosis of GDM implementing both the 2010 IADPSG clinical recommendations and the 2011 NACB laboratory recommendations for the diagnosis of GDM. 2, 11 Another strength of this study is that we have used the IADPSG criteria for the diagnosis of GDM based on a one-step 75-g OGTT, and thus a single abnormal glucose result is more important than previously. The POC procedure was performed by a trained researcher and not by the study participants, thereby minimising the risk of technical error. Finally, the clinical and sociodemographic details for each woman were collected in early pregnancy and validated at the time of the OGTT. The clinical details of the study participants were also well characterised.
A limitation of our study is that further studies are required to evaluate other POC glucose devices and POC devices in other populations. Also, in clinical practice, adjustments of POC diagnostic criteria may depend on updates in POC glucometers and the standards required for accuracy in different healthcare settings.
Interpretation
Our findings are consistent with a previous paired study from our centre: of 24 obese women, 66.7% (n = 16) had an elevated fasting glucose level at their first antenatal visit using the reference standard, compared with 29.2% (n = 7) using customary practices. 15 This is explained by the impact of glycolysis on the fasting sample under customary conditions. 22 The current IADPSG diagnostic criteria for GDM were based on previous NACB laboratory standards (use of an ice slurry and cell separation within 
minutes).
12 It is possible, therefore, that the higher incidence of GDM using the IADPSG criteria and stricter NACB standards (use of an ice slurry and cell separation within 30 minutes) in this study, has resulted in a 'recalibration' of the fasting value. The diagnostic criteria for GDM, particularly the fasting value, therefore may need to be re-examined.
No universal standards for the analytical performance of POC glucose meters exist. 25 The accuracy of meters may be either technical or clinical. 26, 27 The Bland-Altman plots in our study support a strong technical correlation between the POC measurements and the reference measurements but these plots do not evaluate the use of POC measurements in different clinical settings. Error or consensus grids have been developed to evaluate clinical accuracy, but these are used primarily to evaluate meters in patients at risk of hypo-or hyperglycaemia. 28 We have not been able to identify any studies to date which have evaluated POC glucose measurements for the accurate diagnosis of GDM after implementing the latest clinical and laboratory standards as supported by the ADA. In general, the concentration of glucose in capillary blood is not equivalent to the concentration in venous blood. 29 Also, the concentration of glucose in plasma is physiologically more relevant than the concentration in whole blood, which is influenced by the haematocrit (HCT). 30 The technical performance of all POC glucose devices should be evaluated across a defined HCT range in the population, which is particularly important for GDM screening in view of the physiological fall in HCT as pregnancy advances.
A review of currently available POC glucose devices concluded that they are more accurate within the range of physiological levels but that they become less reliable at the lower and higher blood glucose levels. 28 Variations in accuracy compared with laboratory measurements at different levels of capillary glucose is critical because the performance of the individual device may vary depending on whether it is being used for screening purposes, for selfmonitoring in the community or for diagnostic purposes in an acute hospital setting.
Any evaluation of POC glucose measurements in screening for GDM must adjust for falling HCT levels during pregnancy and must perform optimally at a plasma glucose level of 5.0 mmol/l given the importance of FPG criteria when implementing the IAPDSG recommendations. The Bayer CONTOUR â meter can measure glucose within a haematocrit range of 0-70%. 31 These technical considerations, and not any commercial considerations, explain why we chose this particular device for our study and why we adjusted the levels for diagnostic accuracy of GDM based on mathematical modelling of the glucose concentrations compared with the venous reference laboratory standards.
Conclusion
Point-of-care glucose testing with fasting thresholds adjusted for capillary blood was superior in making the diagnosis of GDM in comparison with customary laboratory practices as currently implemented worldwide. Adjusted POC glucose testing has considerable diagnostic potential, particularly in settings where phlebotomy is undertaken offsite from accredited laboratories and where pre-analytical standards are suboptimal.
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